MAP2K7 and breast cancer: There is a clear difference in gene expression profiles between BC-treated Ztm males and the control group, especially with the observed upregulation of Map2k7 (Mitogen-Activated Protein Kinase Kinase 7 or MKK7) and downregulation of several genes.